Monday, October 26, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleNasdaq· January 1, 2026

10 Stock Market Predictions for 2026

View original at nasdaq.com
10 Stock Market Predictions for 2026 Key Points This is the second priciest stock market in history, dating back 155 years, which makes for a challenging environment for investors…
Opening lines of the source · Nasdaq · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Every game-changing tech innovation has endured a bubble-bursting event early in its expansion over the last 30 years

    80% confidence
  • Trump's China tariffs in 2018 and 2019 resulted in average declines in employment, productivity, sales, and profits from 2019 to 2021 for public companies directly affected by these duties

    80% confidence
  • Share buyback activity will hit an all-time high in 2026

    80% confidence
  • Following the previous five occurrences where Shiller P/E topped 30, the Dow, S&P 500, and/or Nasdaq lost 20% to 89% of their value

    80% confidence
  • No company on the leading edge of a next-big-thing tech trend over the last three decades has ever been able to sustain a price-to-sales ratio above 30

    80% confidence
  • The Dow, S&P 500, and Nasdaq Composite will all endure declines of at least 20% in 2026

    80% confidence
  • The Federal Reserve shifts from a stabilizing force to a stock market liability in 2026

    80% confidence
  • Meta Platforms becomes Wall Street's blockbuster stock-split stock of 2026

    80% confidence
  • Stock Advisor's total average return is 979% compared to 195% for the S&P 500

    80% confidence
  • SpaceX should earn its spot atop the largest IPO pedestal in 2026, likely raising $30 billion or more if it commands a valuation of up to $1 trillion

    80% confidence
  • This is the second priciest stock market in history, dating back 155 years, according to the S&P 500's Shiller P/E Ratio

    80% confidence
  • Stagflation will become a regular topic of discussion in 2026

    80% confidence
  • Nvidia ends 2026 as the fourth most valuable public company

    80% confidence
  • We'll witness the largest IPO in history in 2026 and it won't be OpenAI

    80% confidence
  • Trump's tariffs become a corporate earnings scapegoat in 2026

    80% confidence
  • The quantum computing bubble will burst in 2026

    80% confidence
  • Consumer staples will outperform tech stocks in 2026

    80% confidence
  • The 10 best stocks identified by Stock Advisor could produce monster returns in the coming years

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Window: ESMO Data, the Ivonescimab PDUFA and Small-Cap Delistings
Mid-October to November 2026 is a dense catalyst period for clinical-stage biotech. Positive late-stage readouts (ALOFT-IPF, TELIGAN, MIUDELLA, the duvakitug extension) and the ESMO 2026 presentations lead up to the FDA's 14 November PDUFA date for the ivonescimab BLA. At the opposite end of the market, Spago Nanomedical is moving to delist from Nasdaq First North, which shows how hard it is for micro-cap developers to fund themselves. Value is concentrating in companies with late-stage data and near-term regulatory outcomes.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,500 source documents archived
Query this data → isubstrate.com